Pierre Chevallet

775 total citations
32 papers, 640 citations indexed

About

Pierre Chevallet is a scholar working on Organic Chemistry, Molecular Biology and Spectroscopy. According to data from OpenAlex, Pierre Chevallet has authored 32 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Organic Chemistry, 8 papers in Molecular Biology and 5 papers in Spectroscopy. Recurrent topics in Pierre Chevallet's work include Synthesis and biological activity (16 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and Chemical Synthesis and Analysis (5 papers). Pierre Chevallet is often cited by papers focused on Synthesis and biological activity (16 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and Chemical Synthesis and Analysis (5 papers). Pierre Chevallet collaborates with scholars based in France, Türkiye and Poland. Pierre Chevallet's co-authors include Zafer Asım Kaplancıklı, Gülhan Turan‐Zitouni, Ahmet Özdemır, Mehmet Taha Yıldız, Demet Kaya, Jean Martínez, Özgür Devrim Can, Barbara Malawska, Hilmi Burak Kandilci and Kadriye Benkli and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Tetrahedron Letters and European Journal of Medicinal Chemistry.

In The Last Decade

Pierre Chevallet

31 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Chevallet France 11 535 148 61 41 35 32 640
Lidija Šuman Croatia 16 758 1.4× 268 1.8× 47 0.8× 42 1.0× 38 1.1× 24 895
İlhan Işıkdağ Türkiye 8 610 1.1× 139 0.9× 47 0.8× 39 1.0× 31 0.9× 21 703
Ahmed I. Khodair Egypt 20 805 1.5× 222 1.5× 31 0.5× 35 0.9× 20 0.6× 52 905
E.‐S. A. M. BADAWEY Egypt 15 734 1.4× 152 1.0× 38 0.6× 66 1.6× 24 0.7× 41 819
Muammer Kiraz Türkiye 11 771 1.4× 131 0.9× 118 1.9× 48 1.2× 41 1.2× 19 851
Francis A. J. Kerdesky United States 15 475 0.9× 179 1.2× 42 0.7× 50 1.2× 30 0.9× 29 617
Anelia Ts. Mavrova Bulgaria 16 776 1.5× 215 1.5× 80 1.3× 45 1.1× 34 1.0× 36 937
I. Wolska Poland 14 376 0.7× 148 1.0× 48 0.8× 65 1.6× 36 1.0× 67 534
Rikta Saha India 9 529 1.0× 135 0.9× 31 0.5× 76 1.9× 24 0.7× 12 663
Tuğba Ertan‐Bolelli Türkiye 15 530 1.0× 260 1.8× 47 0.8× 32 0.8× 48 1.4× 39 759

Countries citing papers authored by Pierre Chevallet

Since Specialization
Citations

This map shows the geographic impact of Pierre Chevallet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Chevallet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Chevallet more than expected).

Fields of papers citing papers by Pierre Chevallet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Chevallet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Chevallet. The network helps show where Pierre Chevallet may publish in the future.

Co-authorship network of co-authors of Pierre Chevallet

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Chevallet. A scholar is included among the top collaborators of Pierre Chevallet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Chevallet. Pierre Chevallet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaplancıklı, Zafer Asım, et al.. (2008). ChemInform Abstract: Studies on 1,2,4‐Triazole Derivatives as Potential Antiinflammatory Agents.. ChemInform. 39(10).
2.
Kaplancıklı, Zafer Asım, Gülhan Turan‐Zitouni, Ahmet Özdemır, Özgür Devrim Can, & Pierre Chevallet. (2008). Synthesis and antinociceptive activities of some pyrazoline derivatives. European Journal of Medicinal Chemistry. 44(6). 2606–2610. 87 indexed citations
3.
Özdemır, Ahmet, Gülhan Turan‐Zitouni, Zafer Asım Kaplancıklı, & Pierre Chevallet. (2007). Synthesis of some 4-arylidenamino-4H-1,2,4-triazole-3-thiols and their antituberculosis activity. Journal of Enzyme Inhibition and Medicinal Chemistry. 22(4). 511–516. 26 indexed citations
4.
Turan‐Zitouni, Gülhan, Zafer Asım Kaplancıklı, Ahmet Özdemır, et al.. (2007). Studies on 1,2,4‐Triazole Derivatives as Potential Anti‐Inflammatory Agents. Archiv der Pharmazie. 340(11). 586–590. 53 indexed citations
5.
Turan‐Zitouni, Gülhan, Jean‐Alain Fehrentz, Pierre Chevallet, et al.. (2007). Synthesis and Antibacterial Activity of tert‐Butyl [1‐benzyl‐2[(4‐aryl‐2‐thiazolyl)hydrazono]ethyl]carbamate Derivatives. Archiv der Pharmazie. 340(6). 310–314. 3 indexed citations
6.
Turan‐Zitouni, Gülhan, Ahmet Özdemır, Zafer Asım Kaplancıklı, et al.. (2007). Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives. European Journal of Medicinal Chemistry. 43(5). 981–985. 55 indexed citations
7.
8.
Turan‐Zitouni, Gülhan, Zafer Asım Kaplancıklı, Mehmet Taha Yıldız, Pierre Chevallet, & Demet Kaya. (2005). Synthesis and antimicrobial activity of 4-phenyl/cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamido]thio-4H-1,2,4-triazole derivatives. European Journal of Medicinal Chemistry. 40(6). 607–613. 211 indexed citations
9.
Kaplancıklı, Zafer Asım, Gülhan Turan‐Zitouni, & Pierre Chevallet. (2005). Synthesis and antituberculosis activity of new 3-alkylsulfanyl-1,2,4-triazole derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. 20(2). 179–182. 23 indexed citations
10.
Zajdel, Paweł, Andrzej J. Bojarski, Grażyna Chłoń‐Rzepa, et al.. (2003). Preliminary study on application of impregnated synthetic peptide TLC stationary phases for the pre‐screening of 5‐HT1A ligands. Biomedical Chromatography. 17(5). 312–317. 14 indexed citations
11.
12.
Chevallet, Pierre, et al.. (1997). Synthesis of some chroman derivatives and preliminary investigation on their vasodilatory activity.. PubMed. 52(8-9). 569–71. 1 indexed citations
13.
Turan‐Zitouni, Gülhan, Zafer Asım Kaplancıklı, & Pierre Chevallet. (1997). Some new 4-aryl-2-thiazolylhydrazones. Il Farmaco. 52(10). 635–638. 2 indexed citations
14.
Demirayak, Şeref, et al.. (1996). Synthesis of some 1-(2-arylvinyl)-3-arylpyrazino[1,2-a]benzimidazole derivatives and their antimicrobial activities.. PubMed. 51(12). 825–7. 1 indexed citations
15.
Pauvert, B., et al.. (1995). Polymorphisme et analyse du comportement thermique d'une serie de 3-(α-hydroxy imino aryl) 1,2,2-trimethyl cyclopentane carboxylate. Journal of thermal analysis. 45(3). 535–558. 1 indexed citations
16.
Kieć‐Kononowicz, Katarzyna, et al.. (1995). Synthesis and antiarrhythmic properties of basic amide derivatives of imidazolidine-2,4-dione and pyrrolidine-2,5-dione II.. PubMed. 50(5). 355–60. 6 indexed citations
17.
Térol, A., et al.. (1994). Infrared, Raman, and13C NMR Spectra of Two Crystalline Forms of (1R,3S)-3-(p-Thioanisoyl)-1,2,2-trimethylcyclopentanecarboxylic Acid. Journal of Pharmaceutical Sciences. 83(10). 1437–1442. 12 indexed citations
18.
Chevallet, Pierre, et al.. (1993). Facile synthesis of tert-butyl ester of N-protected amino acids with tert-butyl bromide. Tetrahedron Letters. 34(46). 7409–7412. 58 indexed citations
19.
Térol, A., et al.. (1992). Analyse du comportement thermique d'une série d'acides 3-aroyl 1,2,2-triméthyl cyclopentane carboxyliques. Thermochimica Acta. 211. 279–293. 3 indexed citations
20.
Térol, A., et al.. (1986). Application des relations thermodynamiques aux modifications polymorphes d'un derive camphorique. Thermochimica Acta. 107. 189–197. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lidija Šuman Breakdown of academic impact, for papers by İlhan Işıkdağ Breakdown of academic impact, for papers by Ahmed I. Khodair Breakdown of academic impact, for papers by E.‐S. A. M. BADAWEY Breakdown of academic impact, for papers by Muammer Kiraz Breakdown of academic impact, for papers by Francis A. J. Kerdesky Breakdown of academic impact, for papers by Anelia Ts. Mavrova Breakdown of academic impact, for papers by I. Wolska Breakdown of academic impact, for papers by Rikta Saha Breakdown of academic impact, for papers by Tuğba Ertan‐Bolelli
Rankless by CCL
2026